Boroushaki M T
Department of Pharmacology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Comp Biochem Physiol C Toxicol Pharmacol. 2003 Dec;136(4):367-75. doi: 10.1016/j.cca.2003.10.010.
Hexachlorobutadiene (HCBD) is a potent nephrotoxin in rodents that can cause degeneration, necrosis and regeneration in renal tubular epithelial cells. Its toxicity is due to its conjugation by glutathione (GSH) to form glutathione S-conjugate, by the enzyme glutathione S-transferase and finally to the related cysteine-conjugate. This metabolite is then actively taken up by kidney and cleared in the renal tubular epithelial cells, rich in beta-lyase, to a reactive thiol derivative that covalently binds to the macromolecules. In this study, different groups of 28-day male Wistar albino (W/A) rats were dosed daily with 25 mg/kg HCBD for 2, 3, 4 and 7 days; control group dosed with corn oil. Data showed that in the 2- and 3-day treated groups there was substantial necrosis to the straight portion of the proximal tubules (pars recta or S3 segment), rich in glutamine transaminase K (GTK/beta-lyase). In the 4-day treated group, the renal proximal tubules had regenerated and showed a basophilic appearance. In animals treated for 7 days, it was observed that the kidney appeared to have returned to normal and had become resistant to further doses of HCBD. To define the time for the kidney to regain susceptibility to HCBD, 18- and 25-day studies with both low (25 mg/kg) and high (100 mg/kg) doses of HCBD (following two initial doses of 25 mg/kg) were performed. In the 18-day study, histopathological examination of the kidneys in animals of this group and also animals in the 25-day study, which received two further doses of HCBD, showed that the severity of kidney damage is much less than in the 2-day treated animals, a clear indication that the tubular cells were still resistant to the low dose of HCBD. Concentration of blood urea nitrogen, as a marker of kidney damage, in these two groups also confirmed the results. In animals re-exposed to the high dose of HCBD, data showed that the susceptibility to HCBD was starting to return.
六氯丁二烯(HCBD)是一种对啮齿动物有强效肾毒性的物质,可导致肾小管上皮细胞发生变性、坏死和再生。其毒性源于它通过谷胱甘肽硫转移酶与谷胱甘肽(GSH)结合形成谷胱甘肽S - 共轭物,最终形成相关的半胱氨酸共轭物。然后这种代谢物被肾脏主动摄取,并在富含β - 裂解酶的肾小管上皮细胞中被清除,形成一种能与大分子共价结合的活性硫醇衍生物。在本研究中,不同组28日龄雄性Wistar白化大鼠(W/A)每天给予25mg/kg HCBD,持续2、3、4和7天;对照组给予玉米油。数据显示,在2天和3天治疗组中,富含谷氨酰胺转氨酶K(GTK/β - 裂解酶)的近端小管直部(直部或S3段)出现大量坏死。在4天治疗组中,肾近端小管已经再生并呈现嗜碱性外观。在接受7天治疗的动物中,观察到肾脏似乎已恢复正常,并且对进一步剂量的HCBD产生了抗性。为了确定肾脏恢复对HCBD敏感性的时间,进行了18天和25天的研究,使用低剂量(25mg/kg)和高剂量(100mg/kg)的HCBD(在最初两次给予25mg/kg之后)。在18天的研究中,对该组动物以及接受另外两次HCBD剂量的25天研究中的动物的肾脏进行组织病理学检查,结果表明肾脏损伤的严重程度远低于2天治疗的动物,这清楚地表明肾小管细胞对低剂量的HCBD仍具有抗性。作为肾脏损伤标志物的血尿素氮浓度在这两组中也证实了该结果。在再次暴露于高剂量HCBD的动物中,数据显示对HCBD的敏感性开始恢复。